Information
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
No injuries reported. This is a preventive recall action.
Source: CPSC
InfoRecall #25223
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey) · Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
Product Description
This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Hazard
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Refund
411 Press Analysis
The CPSC announced a voluntary recall of Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs on April 10, 2025. The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. This recall covers about 14,250 and was initiated by Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey) as a preventive measure. No injuries have been reported to date. Consumers should stop using the product and obtain a full refund. The recall demonstrates proactive safety compliance by the manufacturer. Consumers can verify whether their product is affected by checking model numbers against the CPSC listing.
More CPSC recalls